InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Grey Michael G, Director. Insider active across 3 companies, notably Horizon Therapeutics Public Ltd Co. Cumulatively, 14 filings have been recorded. History available since 22 July 2021. The latest transaction was disclosed on 19 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Grey Michael G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
50,000 shares@ US$2.93627.3% of flowCommon StockSEC:0001240122-25-000011:0
50,000 shares@ US$2.93638.0% of flowCommon StockSEC:0001240122-25-000007:0
50,000 shares@ US$2.93661.5% of flowCommon StockSEC:0001240122-25-000006:0
102,788 shares0Common StockSEC:0001415889-24-024195:0
39,361 shares@ US$116.5093.1% of flowOrdinary SharesSEC:0001209191-23-052373:0
20,000 shares@ US$15.966.5% of flowOrdinary SharesSEC:0001209191-23-050737:0
392 shares@ US$2.9361.3% of flowCommon StockSEC:0001209191-23-049511:0
50,000 shares0Common StockSEC:0001209191-23-043558:0
14,608 shares@ US$2.93650.0% of flowCommon StockSEC:0001209191-23-035831:0
14,608 shares@ US$2.93648.7% of flowCommon StockSEC:0001209191-23-027549:0
3,913 sharesOrdinary SharesSEC:0001209191-23-026748:0
50,000 shares@ US$1.97100.0% of flowCommon StockSEC:0001209191-22-048532:0
4,223 sharesOrdinary SharesSEC:0001209191-22-026465:0
5,000 shares@ US$2.370.2% of flowOrdinary SharesSEC:0001209191-21-047977:0
14 of 14 declarations
About Grey Michael G
GREY MICHAEL G is Administrateur. He has 14 filings in total. In the recent filings available, which cover the period from 2021-07-23 to 2025-12-23, there were 0 EUR of purchases and 4347887 EUR of sales, with Levée d'options as the most common transaction type. He is listed as Director at Mirum Pharmaceuticals, Inc. and Horizon Therapeutics Public Ltd Co, and as Executive Chairman at Reneo Pharmaceuticals, Inc.
